Limbic Epileptogenesis in a Mouse Model of Fragile X Syndrome

Fragile X syndrome (FXS), caused by silencing of the Fmr1 gene, is the most common form of inherited mental retardation. Epilepsy is reported to occur in 20–25% of individuals with FXS. However, no overall increased excitability has been reported in Fmr1 knockout (KO) mice, except for increased sensitivity to auditory stimulation. Here, we report that kindling increased the expressions of Fmr1 mRNA and protein in the forebrain of wild-type (WT) mice. Kindling development was dramatically accelerated in Fmr1 KO mice, and Fmr1 KO mice also displayed prolonged electrographic seizures during kindling and more severe mossy fiber sprouting after kindling. The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or mGluR5 receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP). The rate of kindling development in WT was not effected by MPEP, however, suggesting that FMRP normally suppresses epileptogenic signaling downstream of metabolic glutamate receptors. Our findings reveal that FMRP plays a critical role in suppressing limbic epileptogenesis and predict that the enhanced susceptibility of patients with FXS to epilepsy is a direct consequence of the loss of an important homeostatic factor that mitigates vulnerability to excessive neuronal excitation.

• Publication year

  2008

• Venue

  Cerebral Cortex

• Publication date

  2008-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cercor/bhn163PMID 18832330PMCID 2693616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabotropic Glutamate Receptors and Fragile X Mental Retardation Protein: Partners in Translational Regulation at the Synapse

  2008influential reference
• Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling.

  2008cited by this paper
• The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules.

  2007cited by this paper
• Drosophila Fragile X Mental Retardation Protein and Metabotropic Glutamate Receptor A Convergently Regulate the Synaptic Ratio of Ionotropic Glutamate Receptor Subclasses

  2007cited by this paper
• Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

  2006cited by this paper
• Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses.

  2006cited by this paper
• Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.

  2006cited by this paper
• Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis.

  2005cited by this paper
• Prolonged Epileptiform Discharges Induced by Altered Group I Metabotropic Glutamate Receptor-Mediated Synaptic Responses in Hippocampal Slices of a Fragile X Mouse Model

  2005influential reference
• Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome.

  2005influential reference
• Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

  2005cited by this paper
• Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein.

  2004cited by this paper
• Visual Experience Regulates Transient Expression and Dendritic Localization of Fragile X Mental Retardation Protein

  2004cited by this paper
• Group I metabotropic glutamate receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits

  2004cited by this paper
• The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation.

  2004cited by this paper
• Metabotropic Glutamate Receptor Activation Regulates Fragile X Mental Retardation Protein and Fmr1 mRNA Localization Differentially in Dendrites and at Synapses

  2004cited by this paper
• The mGluR theory of fragile X mental retardation.

  2004influential reference
• New insights into fragile X syndrome: from molecules to neurobehaviors.

  2003influential reference
• Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome.

  2003cited by this paper
• The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses.

  2003cited by this paper
• RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

  2003cited by this paper
• Whisker stimulation-dependent translation of FMRP in the barrel cortex requires activation of type I metabotropic glutamate receptors.

  2003cited by this paper
• The Drosophila easiry shocked Gene : A Mutation in a Phospholipid Synthetic Pathway Causes Seizure , Neuronal Failure , and Paralysis

  2003cited by this paper
• Faculty Opinions recommendation of Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor.

  2003cited by this paper
• Epilepsy in fragile X syndrome

  2002cited by this paper
• Epilepsy in fragile X syndrome.

  2002cited by this paper
• Identification of mRNA/Protein (mRNP) Complexes Containing Purα, mStaufen, Fragile X Protein, and Myosin Va and their Association with Rough Endoplasmic Reticulum Equipped with a Kinesin Motor*

  2002cited by this paper
• A decade of molecular studies of fragile X syndrome.

  2002cited by this paper
• Influence of stimulants on electrodermal studies in Fragile X syndrome

  2002influential reference
• Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function.

  2001cited by this paper
• Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.

  2001influential reference
• Fragile X mice develop sensory hyperreactivity to auditory stimuli.

  2001influential reference
• Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function

  2001cited by this paper
• Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function.

  2001cited by this paper
• Synaptic regulation of protein synthesis and the fragile X protein

  2001cited by this paper
• The fragile X mental retardation protein inhibits translation via interacting with mRNA.

  2001cited by this paper
• Epilepsy and EEG findings in 18 males with fragile X syndrome.

  2001influential reference
• Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo.

  2000cited by this paper
• Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome

  2000influential reference
• Dendritic spine structural anomalies in fragile-X mental retardation syndrome.

  2000cited by this paper
• Epilepsy and EEG Findings in Males with Fragile X Syndrome

  1999cited by this paper
• Diamondoids and oil are not forever

  1999cited by this paper
• Emerging insights into the genesis of epilepsy

  1999cited by this paper
• Role of metabotropic glutamate receptors in epilepsy.

  1999cited by this paper
• A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine.

  1998cited by this paper
• Glutamate receptors in epilepsy.

  1998cited by this paper
• Purified Recombinant Fmrp Exhibits Selective RNA Binding as an Intrinsic Property of the Fragile X Mental Retardation Protein*

  1998cited by this paper
• A Point Mutation (D79N) of the α2A Adrenergic Receptor Abolishes the Antiepileptogenic Action of Endogenous Norepinephrine

  1998cited by this paper
• Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

  1997influential reference
• Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.

  1997cited by this paper
• Molecular/clinical correlations in females with fragile X.

  1996cited by this paper
• The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals.

  1996cited by this paper
• Null Mutation of c-fos Impairs Structural and Functional Plasticities in the Kindling Model of Epilepsy

  1996influential reference
• Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling.

  1995influential reference
• Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.

  1994cited by this paper
• FMR1 Knockout mice: A model to study fragile X mental retardation

  1994cited by this paper
• Advances in molecular analysis of fragile X syndrome.

  1994influential reference
• FMR1 protein: conserved RNP family domains and selective RNA binding.

  1993cited by this paper
• Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

  1991cited by this paper
• Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.

  1990cited by this paper
• Mossy fiber synaptic reorganization in the epileptic human temporal lobe

  1989cited by this paper
• Conference report: Fourth International Workshop on the fragile X and X-linked mental retardation.

  1988cited by this paper
• Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.

  1988cited by this paper
• Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.

  1988cited by this paper
• Conference report: International Workshop on the fragile X and X-linked mental retardation.

  1984influential reference
• International workshop on the fragile X and X‐linked mental retardation

  1984cited by this paper
• X-linked mental retardation, macro-orchidism, and the Xq27 fragile site.

  1980cited by this paper
• Postseizure inhibition of kindled seizures.

  1977cited by this paper
• Modification of seizure activity by electrical stimulation. 3. Mechanisms.

  1972cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972influential reference
• A permanent change in brain function resulting from daily electrical stimulation.

  1969influential reference
• Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes.

  1966cited by this paper

• Bioisostere-Driven Discovery of SePP: A Selenium-Containing Polypharmacological Agent Relevant to Fragile X Syndrome.

  2026cites this paper
• Compensatory Regulation of Excitation/Inhibition Balance in the Ventral Hippocampus: Insights from Fragile X Syndrome

  2025cites this paper
• Rescue of sharp wave-ripples and prevention of network hyperexcitability in the ventral but not the dorsal hippocampus of a rat model of fragile X syndrome

  2023cites this paper
• Spontaneous seizures in adult Fmr1 knockout mice: FVB.129P2-Pde6b+Tyrc-chFmr1tm1Cgr/J.

  2022cites this paper
• Hyperexcitability and Homeostasis in Fragile X Syndrome

  2022cites this paper
• Kainic acid-induced status epilepticus decreases mGlu5 receptor and phase-specifically downregulates Homer1b/c expression.

  2019cites this paper
• Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder.

  2017cites this paper
• Differential roles of α-, β-, and γ-actin in axon growth and collateral branch formation in motoneurons

  2017cites this paper
• Autism and Fragile X Syndrome

  2017cites this paper
• Differential roles of α -, β -, and γ -actin in axon growth and collateral branch formation in motoneurons

  2017cites this paper
• Treatment of Fragile X Syndrome with a Neuroactive Steroid

  2015cites this paper
• Fragile X syndrome as a rare disease in China - Therapeutic challenges and opportunities.

  2015cites this paper
• Convergence of synaptic pathophysiology in the hippocampus of Fmr1-/y and Syngap1+/- mice

  2015cites this paper
• Involvement of Rho-family GTPases in axon branching

  2014cites this paper
• Stem cells and modeling of autism spectrum disorders.

  2014cites this paper
• From FMRP Function to Potential Therapies for Fragile X Syndrome

  2014cites this paper
• Epilepsy in four genetically determined syndromes of intellectual disability.

  2013cites this paper
• Fragile X syndrome and targeted treatment trials.

  2012cites this paper
• Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.

  2012cites this paper
• Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond

  2012cites this paper
• Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

  2012cites this paper
• Genetic-Background Modulation of Core and Variable Autistic-Like Symptoms in Fmr1 Knock-Out Mice

  2011cites this paper
• Conditional deletion of NRSF in forebrain neurons accelerates epileptogenesis in the kindling model.

  2011cites this paper
• Mechanisms of epileptogenesis and potential treatment targets.

  2011cites this paper
• Transgenic Mouse Models of Childhood Onset Psychiatric Disorders

  2011cites this paper
• Neuron‐restrictive silencer factor is not required for the antiepileptic effect of the ketogenic diet

  2011cites this paper
• Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

  2011cites this paper
• Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome

  2010cites this paper
• Hypersensitivity to mGluR 5 and ERK 1 / 2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome

  2010cites this paper
• Emerging Pharmacotherapies for Neurodevelopmental Disorders

  2010cites this paper
• Fragile X mental retardation protein in the driver's seat.

  2009cites this paper
• Origins of Epilepsy in Fragile X Syndrome

  2009cites this paper